ReviewBrain communications2025
Lance-Adams syndrome or chronic post-hypoxic myoclonus in adults: a systematic literature review.
Review in Brain communications, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Status epilepticus as a novel etiology of Lance-Adams syndrome: a case report.Epilepsy & behavior reports · 2026Article
- Recent advances in clinical neurophysiology of myoclonus.Clinical parkinsonism & related disorders · 2026Article
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Lance-Adams syndrome, or chronic post-hypoxic myoclonus, is a disabling chronic myoclonic disorder occurring in survivors of brain hypoxic events. Using a systematic methodology for literature search and data acquisition, we extensively reviewed all published cases of Lance-Adams syndrome since the first original patients were described by JW Lance and RD Adams in 1963. We analysed the available data of 272 patients extracted from the 153 included studies to summarize the natural history of Lance-Adams syndrome, outline the full spectrum of this disorder and deepen our understanding of its underlying mechanisms. Two-thirds of patients suffered from a respiratory hypoxic leading event. The main causes of anoxia were peri-surgery and anaesthetic accidents, asthma attacks/bronchospasm, cardiac disorders and intoxications/drug overdoses. Many patients exhibited a 'pure' Lance-Adams syndrome, characterized by multi-focal action-induced myoclonic jerks predominant to distal limbs. Morphologic brain imaging did not show any specific abnormalities. Neurophysiological evaluations, including EEG recordings, polymyography of myoclonus and jerk-locked back averaging of myoclonus, revealed features of cortical myoclonus in the majority of patients. Both EEG, showing epileptiform discharges on the frontal and central median regions, and brain metabolism imaging, showing hypometabolism on the pericentral regions, indicated that myoclonus in Lance-Adams syndrome originates within the motor cortex. Some anti-seizure medications have shown some effectiveness and certain neuromodulation techniques have promising effects.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.